Garlan Adams joined Avanir in October 2015 as Vice President and General Counsel. She oversees key aspects of legal support for Avanir. Under her leadership, the Law Department is responsible for counseling Avanir on FDA regulatory matters, product life cycle management, drafting and negotiating commercial and government contracts, employment law, corporate transactions and governance, and assisting the Chief Compliance Officer with the development and enforcement of company and departmental policies.
Garlan’s experience spans over 16 years of pharmaceutical practice. Most recently, she served as Associate General Counsel and Head of Law at Onyx Pharmaceuticals Inc., where she led the transition of Onyx from an independent company to a subsidiary of Amgen Inc. with a shared G&A infrastructure. During this transition, she supported all legal and regulatory matters and commercial transactions, including contract negotiation, drafting, and administration. She also served as a member of Onyx’s senior leadership team, providing strategic legal and business advice in various areas.
Prior to joining Onyx, she served as Director of Global Commercial Operations at Amgen, where she supported the Oncology and Nephrology Business Units and helped implement Amgen’s Corporate Integrity Agreement. She was also Senior Corporate Counsel at Amylin Pharmaceuticals, Inc. and Eli Lilly and Company.
Garlan graduated from Indiana University School of Law, Indianapolis with a Doctor of Law (J.D.). She is a member of the American Bar Association.